Resources for:

    Symposium Agenda

    Agenda for 2013 UW-Whitewater Nanoscience Symposium: Nanomedicine (Friday, October 18, 2013)              

    9:30 am - 10:00 am Pick up Registration Materials and Welcome to Nano 2013 - 1st FloorLobby Upham Hall
    Concurrent Workshop Sessions I (select one): *
    10:10 am - 10:40 am  Nanobiology Workshop - UH 054 (Using the Atomic Force Microscope to Image DNA)
    10:10 am - 10:40 am  Nanochemistry Workshop - UH 246
    10:10 am - 10:40 am  Nanophysics Workshop - Room 155A
    10:10 am - 10:40 am  Nanoproducts and Safety Workshop - UH 244

    Olympus**** Equipment Demo Workshop - UH 206

    (Olympus FV10i Confocal ,BX 53 Microscope, and SZ 61 Stereo Microscope)

    Concurrent Sessions II (select one): *
    10:50 am - 11:20 am  Nanobiology Workshop - UH 054 (Using the Atomic Force Microscope to Image DNA)
    10:50 am - 11:20 am  Nanochemistry Workshop - UH 246
    10:50 am - 11:20 am  Nanophysics Workshop - Room 155A
    10:50 am - 11:20 am  Nanoproducts and Safety Workshop - UH 244
     

     Olympus**** Equipment Demo Workshop - UH 206

    (Olympus FV10i Confocal ,BX 53 Microscope, and SZ 61 Stereo Microscope)

    11:30 am - 12:00 pm Free Time/Lunch on Your Own
    12:05 pm - 12:55 pm

    Panel Discussion - Nano Science Career and Research Opportunities - UH145

    Abdalla Saad, Co-D Therapeutics, Inc ***based in Madison, WI

    Seungpyo Hong, University of Illinois at Chicago

    Jeffrey Leicht, Olympus America

    1:00 pm - 2:00 pm Poster Session - 1st floor Lobby, Upham Hall
    2:15 pm - 3:25 pm Keynote Presentation - Dr. Seungpyo Hong, University of Illinois at Chicago, Closing Session, & Poster Awards (Upham Hall, Room 145)

    *For Registered Attendees Only. If attending both Workshop Sessions, make sure to choose two different session types, as workshops in Session1 are the same as the Session 2.

    *** Co-D Therapeutics, Inc. based in Madison, WI, is an innovative drug development company dedicated to bringing to market first-in-class, combination nanomedicines with high safety profiles to treat cancer and improve patients' lives. Co-D's polymeric platform technology focuses on the formulation and delivery of multiple anticancer agents in a single novel therapeutic. Co-D is developing its nano-medicine lead product, Triolimus, to treat the rare malignancy angiosarcoma under an orphan drug designation, breast cancer and non-small cell lung cancer. Triolimus will replace less efficacious, less safe, and more complex conventional combination chemotherapy regimens in clinical practice. 

    **** Olympus is also a world leader in research and clinical microscopes. We created the first practical camera that lets doctors look inside the human body, and we continue to introduce life-altering imaging technologies for healthcare professionals. We pride ourselves on enriching people's lives, around the world, every day.

                                                          

    Location

    College of Letters & Sciences
    Laurentide Hall 4100
    University of Wisconsin-Whitewater
    800 W. Main Street
    Whitewater, WI 53190-1790

    Contact

    Office of the Dean
    Phone: (262) 472-1621
    E-mail: lamkinn@uww.edu

    Follow Us

    107.22.45.61